Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
68 participants
INTERVENTIONAL
2018-02-26
2018-04-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
50 Human Subject Repeat Insult Patch Test
NCT04498676
NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test
NCT03522675
Repeat Insult Patch Test APPENDIX I to HRL Standard Protocol #100
NCT03450070
Cumulative Irritation Patch Test
NCT01842711
DermAI to Evaluate Human Factor of Testing
NCT06387472
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Collagen Dressing and Comparator
NeoMatriX Collagen Dressing and Comparators - positive control and normal saline will be applied to the absorbent pad portion of the exclusive dressing.
NeoMatriX Collagen Dressing
Collagen wound dressing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NeoMatriX Collagen Dressing
Collagen wound dressing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects must understand and execute an Informed Consent Form that includes a HIPAA statement;
* Subjects must be considered dependable and able to follow directions
Exclusion Criteria
* Subjects who are taking medications other than birth control;
* Female subjects who are pregnant (return positive urine pregnancy test), planning to become pregnant or lactating during the course of the trial;
* Subjects who have a history of adverse reactions to personal care products, or known sensitivity to the test materials or their constituents including patch materials;
* Subjects with any active skin disease;
* Subjects who have heavy alcohol consumption;
* Subjects with current use or history of repeated use of street drugs;
* Subjects with a significant past medical history to potentially effect results of study;
* Subjects with immunization less than 10 days prior to the test patch application;
18 Years
79 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NeXtGen Biologics, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Consumer Product Testing Company, Inc.
Fairfield, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NNAU01-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.